Consultant Live previewed the upcoming American Thoracic Society’s (ATS) International Conference, a four-day conference that features the latest advances in pulmonary, critical care and sleep medicine. The preview highlighted an upcoming expert interview with Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, on results from the Phase 3 MATINEE clinical trial assessing mepolizumab in patients with chronic obstructive pulmonary disease (COPD) and findings from the Aiflow-3 clinical trial to determine the impact of targeted lung denervation on COPD exacerbations.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH